Skip to main content
FinSpry Logo
FinSpry
NGNE logo
NGNE
(NASDAQ)
Neurogene Inc.
$20.69-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Neurogene (NGNE) Stock Price & Financial Analysis

Neurogene Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.87 - $22.08
52-Week High$37.27
52-Week Low$6.88
Open$21.02
Volume173.66K
Average Volume (3M)173.66K
Market Cap437.97M
Shares Outstanding21.17M
Price to Book (P/B)1.73
EV/EBITDA-4.86
50-Day MA$19.69
200-Day MA$21.27
52-Week Change124.34%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Neurogene

What is the current stock price for NGNE?

As of the latest trading session, NGNE stock trades at $20.69. The 52-week range is $6.88–$37.27, with a day range of $19.87–$22.08.

What is the P/E ratio for NGNE?

The P/E ratio (Price-to-Earnings) for NGNE is shown in the Key Statistics section. This valuation metric helps compare Neurogene Inc. to industry peers.

Does NGNE pay dividends?

Neurogene does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NGNE?

Based on 3 analysts, the consensus for NGNE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NGNE?

Neurogene's market capitalization is $438.0M, classifying it as a small-cap company. Neurogene operates in the Healthcare sector within the Biotechnology industry.